ArticleBMC cancer2008

Anti-angiogenesis therapy based on the bone marrow-derived stromal cells genetically engineered to express sFlt-1 in mouse tumor model.

M Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.